Join us for a virtual KOL event with Alligator Bioscience, featuring Dr. Zev Wainberg, Professor of Medicine at University of California, Los Angeles (UCLA) and co-director of the UCLA Gastrointestinal (GI) Oncology Program, who will discuss the unmet medical need and current treatment landscape for patients suffering from metastatic pancreatic cancer, along with the potential for mitazalimab to provide an effective and safe first-line treatment solution.

Additionally, in a discussion moderated by Alligator CMO Dr. Sumeet Ambarkhane, we will provide insights into the latest interim efficacy readout and survival data from the Phase 2 OPTIMIZE-1 study evaluating CD40 agonist mitazalimab in combination with chemotherapy (mFOLFIRINOX) in 1st line metastatic pancreatic cancer.

A live question and answer session will follow the formal presentations.